SCHEMBL29869664

SCHEMBL29869664

CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(OC(C)(C)C)cc1)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)OC(C)(C)C)NC(=O)C(C)(C)NC(=O)[C@H](Cc1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1)NC(=O)OCC1c2ccccc2-c2ccccc21)[C@@H](C)OC(C)(C)C)[C@@H](C)OC(C)(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)OC(C)(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 12/20 0.44
▸ OPRK1 P41145 10/20 0.44
▸ OPRD1 P41143 9/20 0.44
▸ GLP1R P43220 6/20 0.41
▸ SCTR P47872 1/20 0.41
▸ GRB2 P62993 1/20 0.39
▸ TFPI P10646 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31015874 0.94 PTPN1 (0.39) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30884234 0.91 OPRM1 (0.44) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL29377572 0.89 GLP1R (0.53) GLP1R
SCHEMBL31255808 0.89 OPRM1 (0.43) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL31567827 0.88 GLP1R (0.44) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30343345 0.88 OPRM1 (0.45) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30175817 0.88 OPRM1 (0.40) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30836835 0.87 OPRM1 (0.40) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30175807 0.86 REN (0.39) OPRM1OPRK1OPRD1GLP1RSCTR
SCHEMBL30662558 0.86 OPRM1 (0.43) OPRM1OPRK1OPRD1GRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447535-B2 GLP-1 analogues SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2022-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11447535-B2 GLP-1 analogues GLP1R, GIPR, GPR119 OPRM1 767/4885OPRK1 705/4885OPRD1 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback